Clinical Study
Comprehensive Look at Blood Transfusion Utilization in Total Joint Arthroplasty at a Single Academic Medical Center under a Single Surgeon
Table 4
Transfused versus Nontransfused patients.
| ā | ā | TKA | value | TKA-R | value | THA | value | THA-R | value |
| Age | Not transfused | 62.0 | 0.007 | 61.3 | 0.004 | 56.1 | 0.07 | 52.8 | 0.06 | Transfused | 65.1 | 69.0 | 61.8 | 59.2 | LOS | Not transfused | 3.4 | 0.03 | 3.8 | 0.09 | 3.5 | 0.04 | 4.0 | 0.43 | Transfused | 3.8 | 4.6 | 4.1 | 5.7 | Pre-op HCT | Not transfused | 40.5 | 0.001 | 38.7 | 0.001 | 40.4 | 0.001 | 40.5 | 0.008 | Transfused | 37.3 | 34.3 | 37.4 | 36.5 | EBL | Not transfused | 57 | 0.05 | 96 | 0.008 | 279 | 0.03 | 736 | 0.003 | Transfused | 75 | 285 | 349 | 1326 | Comorbidities | Not transfused | 2.92 | 0.2 | 2.08 | 0.07 | 2.52 | 0.07 | 2.29 | 0.002 | Transfused | 3.07 | 3.27 | 2.74 | 3.03 |
|
|